Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Breaking Ground in Bone Health: Key Takeaways from ISO 2025
On the Frontlines of OsteoporosisBreaking Ground in Bone Health: Key Takeaways from ISO 2025
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Project Oncology®HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
CME/CEThe Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
CME/CE Broadcast ReplayNew Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
CME/CECreating a Practice Environment That Enhances Healthcare Equality for All Patients
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Medical Industry FeatureTreating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Medical Industry FeatureEMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Advancing the Transabdominal Cerclage Through Robotics
Medical Industry FeatureAdvancing the Transabdominal Cerclage Through Robotics
Navigating How the Updated ASCCP Guidelines Can Work for You
Medical Industry FeatureNavigating How the Updated ASCCP Guidelines Can Work for You
The Value of CINtec®PLUS Cytology Test in Cervical Cancer Screening
Advances in Women's HealthThe Value of CINtec®PLUS Cytology Test in Cervical Cancer Screening
- 05/08/2025
- 05/08/2025
- 05/08/2025
- 05/08/2025
- 05/08/2025
- 05/07/2025